RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 61.39
-2.43 (-3.81%)
Jun 5, 2025, 2:45 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 31.74 billion as of June 5, 2025. Its market cap has increased by 24.54% in one year.
Market Cap
31.74B
Enterprise Value
33.71B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
61.39
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 31.74B, an increase of 11.28%. That is a compound annual growth rate of 2.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 31.74B | 141.21% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |